Esposito Pamela Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$7.65M

Insider Activity of Esposito Pamela

According to the SEC Form 4 filings, Esposito Pamela, being in a position of

  1. director at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 38063 shares for $3.05M,
    over all time since 2024-09-17, has bought 0 shares, and sold 59063 shares for $4.07M.

Biography of Esposito Pamela

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$3,054,1494100

Comparison of Insiders on Amount of Buys and Sells

2026-03-20SaleKymera Therapeutics, Inc.
KYMR
director
2,500
0.0031%
$79.15$197,877+38.01%
2026-02-20SaleKymera Therapeutics, Inc.
KYMR
director
2,500
0.0032%
$87.31$218,270+19.89%
2026-01-20SaleKymera Therapeutics, Inc.
KYMR
director
5,500
0.0069%
$67.91$373,521+32.71%
2025-12-17SaleKymera Therapeutics, Inc.
KYMR
director
27,563
0.0383%
$82.16$2.26M+6.52%
2025-06-03SaleKymera Therapeutics, Inc.
KYMR
director
5,000
0.0086%
$49.04$245,186+52.87%
2024-12-02SaleKymera Therapeutics, Inc.
KYMR
director
2,500
0.0039%
$49.00$122,500-10.75%
2024-09-17SaleKymera Therapeutics, Inc.
KYMR
director
13,500
0.0216%
$48.28$651,766-10.4%
2023-09-12SaleReplimune Group, Inc.
REPL
Chief Business Officer
300
0.0005%
$20.00$6,000-54.46%
2023-09-11SaleReplimune Group, Inc.
REPL
Chief Business Officer
5,358
0.0092%
$20.01$107,214-55.86%
2023-08-22SaleReplimune Group, Inc.
REPL
Chief Business Officer
18,600
0.0315%
$20.01$372,186-56.41%
2023-08-11SaleReplimune Group, Inc.
REPL
Chief Business Officer
1,400
0.0024%
$20.00$28,000-56.32%
2023-07-10SaleReplimune Group, Inc.
REPL
Chief Business Officer
20,000
0.035%
$21.58$431,541-58.78%
2023-05-16SaleReplimune Group, Inc.
REPL
Chief Business Officer
5,966
0.01%
$18.05$107,686-39.05%
2022-12-09SaleReplimune Group, Inc.
REPL
Chief Business Officer
15,000
0.026%
$25.03$375,450-21.52%
2022-05-16SaleReplimune Group, Inc.
REPL
Chief Business Officer
3,507
0.0065%
$14.59$51,167+32.21%
2021-08-05SaleReplimune Group, Inc.
REPL
Chief Business Officer
25,800
0.0478%
$35.09$905,322-43.94%
2021-08-04SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,200
0.0081%
$35.00$147,000-41.71%
2021-07-21SaleReplimune Group, Inc.
REPL
Chief Business Officer
12,538
0.0239%
$33.17$415,885-36.47%
2021-07-20SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,862
0.0093%
$33.05$160,689-34.38%
2021-07-15SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,600
0.0092%
$33.37$153,502-26.1%
Total: 25
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.